Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?

Int J Gynaecol Obstet. 2002 Feb;76(2):175-6. doi: 10.1016/s0020-7292(01)00531-8.
No abstract available

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Antiretroviral Therapy, Highly Active / adverse effects
  • Female
  • Fetal Death
  • HIV Infections / drug therapy*
  • HIV Infections / transmission
  • HIV Protease Inhibitors / adverse effects*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Outcome
  • Reverse Transcriptase Inhibitors / adverse effects
  • Zidovudine / adverse effects

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Zidovudine